Skip to content

Study on non-exercise test regression equation for predicting anaerobic threshold oxygen uptake and peak oxygen uptake in patients with coronary heart disease

Study on non-exercise test regression equation for predicting anaerobic threshold oxygen uptake and peak oxygen uptake in patients with coronary heart disease

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037835
Enrollment
Unknown
Registered
2020-09-02
Start date
2020-06-09
Completion date
Unknown
Last updated
2020-11-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Heart Disease

Interventions

Exercise prescription treatment group using anaerobic threshold method:Application of anaerobic threshold exercise prescription (exercise intensity is anaerobic threshold intensity), 12-week aerobic t
Non-exercise test regression equation exercise prescription treatment group using optimized anaerobic threshold oxygen uptake:Optimal anaerobic threshold oxygen uptake regression equation exercise pre
Optimized peak oxygen uptake non-exercise test regression equation exercise prescription treatment group:Optimize peak oxygen uptake regression equation exercise prescription (exercise intensity is 60

Sponsors

Shanghai Xuhui District Central Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with coronary heart disease who met the diagnostic criteria of the Ministry of health of the people's Republic of China in 2010, and the coronary artery DSA examination showed multiple coronary artery lesions; 2. Patients with low and medium risk of coronary heart disease according to the cardiovascular disease professional committee of Chinese Rehabilitation Medical Association in 2006; 3. Low risk patients: no angina symptoms or ischemic changes in ECG during exercise or recovery period, no complex arrhythmia caused by rest or exercise, and left ventricular ejection fraction > 50%; 4. Moderate risk patients: moderate exercise (5.0-6.9mets) or angina pectoris symptoms or ECG ischemic changes during recovery period, no complex ventricular arrhythmia during rest or exercise, and left ventricular ejection fraction (LVEF) of 40-49%; 5. Patients aged 30-80 years old; 6. Patients who agree to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with understanding and cognitive disorders and mental disorders; 2. Patients with unstable angina pectoris or myocardial infarction within 2 weeks; 3. Patients with uncontrolled serious arrhythmia; 4. Patients who are not easy to control hypertension; 5. Patients whose resting heart rate is still more than 100 beats / min after drug control; 6. Patients with grade 4 cardiac function; 7. Patients with coronary heart disease with acute complications and patients with coronary heart disease classified as high risk by cardiac rehabilitation risk; 8. Patients with pericarditis or myocarditis in active stage; 9. Patients with chronic obstructive pulmonary disease; 10. Patients with severe infection; 11. Patients with moderate or above aortic stenosis; 12. Patients with new deep vein thrombosis and thrombophlebitis; 13. Patients with aortic dissection and other aneurysms; 14. Patients with arteriosclerosis obliterans of lower limbs; patients with physical intolerance to exercise and limb motor dysfunction after stroke; 15. Patients with abnormal water, electrolyte and metabolism.

Design outcomes

Primary

MeasureTime frame
age;gender;Heart Rate of Rest;6-minute walking test exercise maximum heart rate;6-minute walking test final distance;Anaerobic threshold oxygen uptake;Peak oxygen uptake;Height;Weight;Percentage of body fat;Lung volume;Forced expiratory volume in one second, FEV1;Left ventricular ejection fraction,LVEF;

Countries

China

Contacts

Public ContactQing Li

Shanghai Xuhui District Central Hospital

qinglee126@126.com+86 13918874885

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026